eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Gemzar, Citodon Forte, Cetiprin Novum, Estradurin for a Male patient aged 79

This is a personalized study for a 79 year old male patient. The study is created by eHealthMe based on reports of 16 people who take the same drugs and have drug interactionsfrom FDA.

On Oct, 28, 2014: 16 people who reported to have interactions when taking Gemzar, Citodon Forte, Cetiprin Novum, Estradurin are studied

Trend of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin's drug interactions, side effects, and effectiveness reports (3138971)

Information of the patient in this study:

Age: 79

Gender: male

Conditions: Prostate Cancer

Drugs taking:
- Gemzar: used for < 1 month
- Citodon Forte
- Cetiprin Novum
- Estradurin

Drug interactions have: Weight Decreased, Oedema Peripheral, Obstructive Uropathy, Hydronephrosis, Haemoglobin Decreased, Blood Urea Increased, Blood Creatinine Increased, Asthenia

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 79 (±5):

InteractionNumber of reports
Weight Decreased2 (100.00%)
Oedema Peripheral (superficial swelling)2 (100.00%)
Obstructive Uropathy (a blockage that prevents urine from leaving your kidneys)2 (100.00%)
Hydronephrosis (water inside the kidney)2 (100.00%)
Haemoglobin Decreased2 (100.00%)
Blood Urea Increased2 (100.00%)
Blood Creatinine Increased2 (100.00%)
Asthenia (weakness)2 (100.00%)

Most common interactions experienced by males aged 79 (±5) in the use of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin:

InteractionNumber of reports
Weight Decreased2
Oedema Peripheral (superficial swelling)2
Hydronephrosis (water inside the kidney)2
Weakness2
Asthenia (weakness)2
Haemoglobin Decreased2
Obstructive Uropathy (a blockage that prevents urine from leaving your kidneys)2
Renal Disorder Nos2
Obstruction Nos2
Blood Urea Increased2

Most common interactions experienced by males aged 79 (±5) in long term use of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Weight Decreased4 (25.00%)
Oedema Peripheral (superficial swelling)4 (25.00%)
Obstructive Uropathy (a blockage that prevents urine from leaving your kidneys)2 (12.50%)
Hydronephrosis (water inside the kidney)4 (25.00%)
Haemoglobin Decreased2 (12.50%)
Blood Urea Increased2 (12.50%)
Blood Creatinine Increased2 (12.50%)
Asthenia (weakness)3 (18.75%)

Most common interactions experienced by people in the use of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin:

InteractionNumber of reports
Superior Sagittal Sinus Thrombosis (blood clot in the dural venous sinuses, which drain blood from the brain)6
Interstitial Lung Disease4
Hydronephrosis (water inside the kidney)4
Oedema Peripheral (superficial swelling)4
Deep Vein Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)4
Dehydration (dryness resulting from the removal of water)4
Weight Decreased4
Pyrexia (fever)4
Pulmonary Oedema Nos2
Sedation2

Most common interactions experienced by people in long term use of Gemzar, Citodon Forte, Cetiprin Novum, Estradurin:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.